The Effect of Denosumab on Muscle and Strength and Insulin Sensitivity
Recruiting
Phase 4
Interventional Study
Osteoporosis
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 40 and older
- Sex
- Female
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 40 (estimated)
- Sponsor
- Aarhus University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Randomized, placebo controlled prospective trial evaluating the effect of denosumab on insulin sensitivity and muscle strength.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Postmenopausal women (postmenopausal for at least two years)
* Age ≥ 40 years
* BMD T-score ≥ -2.0 (lumbar spine, total hip or femoral neck)
* At least 2 lumbar vertebrae that can be evaluated by dual-energy x-ray absorptiometry (DXA)
* Diabetes Mellitus type 2
* Treatment wit…
Contacts